What is the recommended amlodipine dosing for an adult with stage 2 hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amlodipine Dosing for Stage 2 Hypertension

For stage 2 hypertension, start amlodipine at 5 mg once daily as part of initial combination therapy with a second antihypertensive agent from a different class, preferably in a single-pill combination (SPC). 1, 2

Initial Dosing Strategy

The 2025 AHA/ACC guidelines explicitly state that most patients with stage 2 hypertension require at least 2 classes of antihypertensive agents 1, 2. Initial combination therapy with 2 drugs is reasonable in adults with stage 2 hypertension (defined as SBP ≥20 mm Hg and DBP ≥10 mm Hg from target) 1, 2.

Specific Amlodipine Dosing:

  • Starting dose: 5 mg once daily 3
  • Maximum dose: 10 mg once daily 3
  • Titration timing: Wait 7-14 days between dose adjustments 3
  • Rapid titration is acceptable if clinically warranted with frequent patient assessment 3

Dose Modifications for Special Populations

For small, fragile, elderly patients, or those with hepatic insufficiency:

  • Start at 2.5 mg once daily 3
  • This lower starting dose should also be used when adding amlodipine to existing antihypertensive therapy 3

For patients with renal impairment:

  • No dose adjustment needed; use the usual initial dose 3

Titration Approach

After initiating amlodipine 5 mg, assess response at 7-14 days. If blood pressure remains uncontrolled, increase to 10 mg once daily 3. Research demonstrates that titration from 5 mg to 10 mg produces significant additional blood pressure reductions (approximately -12 to -13 mmHg systolic and -7 to -8 mmHg diastolic) 4.

Important caveat: One study suggests waiting a full 6 weeks before increasing the dose, as 84% of patients achieved target BP with 5 mg when given adequate time 5. However, the FDA label and clinical practice support more rapid titration (7-14 days) when clinically indicated 3.

Combination Therapy Considerations

The guidelines strongly favor SPCs over separate pills because they:

  • Improve medication adherence 1, 2
  • Reduce cardiovascular events and all-cause mortality in observational studies 1, 2
  • Are cost-effective alternatives to multiple-pill regimens 1, 2

Preferred combinations with amlodipine:

  • ACE inhibitor or ARB (not both together) 1, 2
  • Thiazide-type diuretic 1, 2

Avoid combining:

  • Two dihydropyridine CCBs 1, 2
  • ACE inhibitor + ARB (increases CVD, kidney disease, and hyperkalemia risk) 1, 2

Monitoring Considerations

Amlodipine reaches steady-state plasma levels after 7-8 days of consecutive daily dosing 3, with a terminal elimination half-life of 30-50 hours 3. This long half-life provides:

  • Effective 24-hour blood pressure control 6
  • Maintained BP control even if a dose is missed 7
  • Once-daily dosing that improves adherence 1, 2

Common Pitfalls

In older adults: Be cautious with initial dosing and monitoring, as hypotension or orthostatic hypotension may develop 1, 2. The stepped-care approach (starting with monotherapy) remains reasonable in older adults with history of hypotension or multiple drug-associated side effects 1, 2.

Drug interactions: Strong CYP3A inhibitors (itraconazole, clarithromycin) may significantly increase amlodipine levels 3. Amlodipine increases simvastatin exposure by 77% 3 and can increase cyclosporine and tacrolimus levels 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.